eFFECTOR Therapeutics, Inc. Warrant
EFTRW
EFTRW was delisted on the 2nd of July, 2024.
12 hedge funds and large institutions have $534K invested in eFFECTOR Therapeutics, Inc. Warrant in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 4 closing their positions.
25% less funds holding
Funds holding: 16 → 12 (-4)
33% less capital invested
Capital invested by funds: $798K → $534K (-$263K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$19.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$8.85K |
| 2 |
EPM
Equitec Proprietary Markets
Chicago,
Illinois
|
-$8K |
| 3 |
CL
CSS LLC
Chicago,
Illinois
|
-$7K |
| 4 |
HF
HRT Financial
New York
|
-$4K |
| 5 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$2.75K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Aristeia Capital
Greenwich,
Connecticut
| $264K | -$8.85K | -56,613 | -4% |
|
|
2
Goldman Sachs
New York
| $128K | +$19.5K | +125,000 | +25% |
|
|
WA
3
Whitebox Advisors
Minneapolis,
Minnesota
| $61K | – | – | – |
|
|
MI
4
MMCAP International
Grand Cayman,
Cayman Islands
| $30K | – | – | – |
|
|
PA
5
Parallel Advisors
San Francisco,
California
| $13K | – | – | – |
|
|
CH
6
CVI Holdings
Wilmington,
Delaware
| $10K | -$2.75K | -17,596 | -26% |
|
|
ECM
7
Evolution Capital Management
Crystal Bay,
Nevada
| $10K | – | – | – |
|
|
ICM
8
III Capital Management
Boca Raton,
Florida
| $7K | – | – | – |
|
|
TCM
9
Tenor Capital Management
New York
| $7K | – | – | – |
|
|
JG
10
Jefferies Group
New York
| $2.03K | – | – | – |
|
|
WAM
11
Wolverine Asset Management
Chicago,
Illinois
| $2K | -$918 | -5,874 | -32% |
|
|
EPM
12
Equitec Proprietary Markets
Chicago,
Illinois
| – | -$8K | -37,700 | Closed |
|
|
CL
13
CSS LLC
Chicago,
Illinois
| – | -$7K | -28,389 | Closed |
|
|
HF
14
HRT Financial
New York
| – | -$4K | -20,209 | Closed |
|
15
UBS Group
Zurich,
Switzerland
| – | -$1K | -2,929 | Closed |
|
EFTRW Hedge Fund Activity: Q3 2022 in Review
12 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in eFFECTOR Therapeutics, Inc. Warrant (EFTRW) for Q3 2022, worth a combined $534K — down 33% from $798K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of EFTRW and 0 opened new positions — a net loss of 4 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was Goldman Sachs, adding an estimated $19.5K. The largest seller was Aristeia Capital, cutting an estimated $8.85K.
- 12 institutional investors held eFFECTOR Therapeutics, Inc. Warrant (EFTRW) as of Q3 2022, down from 16 in Q2 2022.
- Funds reported $534K of eFFECTOR Therapeutics, Inc. Warrant stock for Q3 2022, down 33% quarter-over-quarter.
- 0 funds opened new eFFECTOR Therapeutics, Inc. Warrant positions in Q3 2022 and 4 closed out, a net change of -4 holders.
- The largest eFFECTOR Therapeutics, Inc. Warrant buyer in Q3 2022 was Goldman Sachs, an estimated $19.5K added.
- The largest eFFECTOR Therapeutics, Inc. Warrant seller in Q3 2022 was Aristeia Capital, an estimated $8.85K sold.
Based on aggregated 13F filings for Q3 2022.